The history of cancer epigenetics (original) (raw)

• Feinberg, A. P. & Vogelstein, B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301, 89–92 (1983).
  CAS PubMed Google Scholar
• Gama-Sosa, M. A. et al. The 5-methylcytosine content of DNA from human tumors. Nucleic Acids Res. 11, 6883–6894 (1983).
  CAS PubMed PubMed Central Google Scholar
• Goelz, S. E., Vogelstein, B., Hamilton, S. R. & Feinberg, A. P. Hypomethylation of DNA from benign and malignant human colon neoplasms. Science 228, 187–190 (1985).
  CAS PubMed Google Scholar
• Feinberg, A. P., Gehrke, C. W., Kuo, K. C. & Ehrlich, M. Reduced genomic 5-methylcytosine content in human colonic neoplasia. Cancer Res. 48, 1159–1161 (1988).
  CAS PubMed Google Scholar
• Strichman-Almashanu, L. Z. et al. A genome-wide screen for normally methylated human CgG islands that can identify novel imprinted genes. Genome Res. 12, 543–554 (2002).
  CAS PubMed PubMed Central Google Scholar
• Feinberg, A. P. & Vogelstein, B. Hypomethylation of ras oncogenes in primary human cancers. Biochem. Biophys. Res. Commun. 111, 47–54 (1983).
  CAS PubMed Google Scholar
• De Smet, C. et al. The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. Proc. Natl Acad. Sci. USA 93, 7149–7153 (1996).
  CAS PubMed PubMed Central Google Scholar
• Cho, B. et al. Promoter hypomethylation of a novel cancer/testis antigen gene CAGE is correlated with its aberrant expression and is seen in premalignant stage of gastric carcinoma. Biochem. Biophys. Res. Commun. 307, 52–63 (2003)
  CAS PubMed Google Scholar
• Adorjan, P. et al. Tumour class prediction and discovery by microarray-based DNA methylation analysis. Nucleic Acids Res. 30, e21 (2002).
  PubMed PubMed Central Google Scholar
• Iacobuzio-Donahue, C. A. et al. Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. Am. J. Pathol. 162, 1151–1162 (2003).
  CAS PubMed PubMed Central Google Scholar
• Oshimo, Y. et al. Promoter methylation of cyclin D2 gene in gastric carcinoma. Int. J. Oncol. 23, 1663–1670 (2003).
  CAS PubMed Google Scholar
• Akiyama, Y., Maesawa, C., Ogasawara, S., Terashima, M. & Masuda, T. Cell-type-specific repression of the maspin gene is disrupted frequently by demethylation at the promoter region in gastric intestinal metaplasia and cancer cells. Am. J. Pathol. 163, 1911–1919 (2003).
  CAS PubMed PubMed Central Google Scholar
• Cho, M. et al. Hypomethylation of the MN/CA9 promoter and upregulated MN/CA9 expression in human renal cell carcinoma. Br. J. Cancer 85, 563–567 (2001).
  CAS PubMed PubMed Central Google Scholar
• Nakamura, N. & Takenaga, K. Hypomethylation of the metastasis-associated S100A4 gene correlates with gene activation in human colon adenocarcinoma cell lines. Clin. Exp. Metastasis 16, 471–479 (1998).
  CAS PubMed Google Scholar
• Badal, V. et al. CpG methylation of human papillomavirus type 16 DNA in cervical cancer cell lines and in clinical specimens: genomic hypomethylation correlates with carcinogenic progression. J. Virol. 77, 6227–6234 (2003).
  PubMed PubMed Central Google Scholar
• De Capoa, A. et al. DNA demethylation is directly related to tumour progression: evidence in normal, pre-malignant and malignant cells from uterine cervix samples. Oncol. Rep. 10, 545–549 (2003).
  CAS PubMed Google Scholar
• Sato, N. et al. Frequent hypomethylation of multiple genes overexpressed in pancreatic ductal adenocarcinoma. Cancer Res. 63, 4158–4166 (2003).
  CAS PubMed Google Scholar
• Piyathilake, C. J. et al. Race- and age-dependent alterations in global methylation of DNA in squamous cell carcinoma of the lung (United States). Cancer Causes Control 14, 37–42 (2003).
  CAS PubMed Google Scholar
• Lengauer, C., Kinzler, K. W. & Vogelstein, B. DNA methylation and genetic instability in colorectal cancer cells. Proc. Natl Acad. Sci. USA 94, 2545–2550 (1997).
  CAS PubMed PubMed Central Google Scholar
• Pao, M. M. et al. DNA methylator and mismatch repair phenotypes are not mutually exclusive in colorectal cancer cell lines. Oncogene 19, 943–952 (2000).
  CAS PubMed Google Scholar
• Kane, M. F. et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair- defective human tumor cell lines. Cancer Res. 57, 808–811 (1997).
  CAS PubMed Google Scholar
• Cui, H., Horon, I. L., Ohlsson, R., Hamilton, S. R. & Feinberg, A. P. Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability. Nature Med. 4, 1276–1280 (1998).
  CAS PubMed Google Scholar
• Qu, G. Z., Grundy, P. E., Narayan, A. & Ehrlich, M. Frequent hypomethylation in Wilms tumors of pericentromeric DNA in chromosomes 1 and 16. Cancer Genet. Cytogenet. 109, 34–39 (1999).
  CAS PubMed Google Scholar
• Yeh, A. et al. Chromosome arm 16q in Wilms tumors: unbalanced chromosomal translocations, loss of heterozygosity, and assessment of the CTCF gene. Genes Chromosomes Cancer 35, 156–163 (2002).
  CAS PubMed Google Scholar
• Hansen, R. S. et al. The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome. Proc. Natl Acad. Sci. USA 96, 14412–14417 (1999).
  CAS PubMed PubMed Central Google Scholar
• Xu, G. L. et al. Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature 402, 187–191 (1999).
  CAS PubMed Google Scholar
• Okano, M., Bell, D. W., Haber, D. A. & Li, E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99, 247–257 (1999).
  CAS PubMed Google Scholar
• Eden, A., Gaudet, F., Waghmare, A. & Jaenisch, R. Chromosomal instability and tumors promoted by DNA hypomethylation. Science 300, 455 (2003).
  CAS PubMed Google Scholar
• Suter, C. M., Martin, D. I. & Ward, R. L. Hypomethylation of L1 retrotransposons in colorectal cancer and adjacent normal tissue. Int. J. Colorectal Dis. 8 Oct 2003 (doi: 10.1007/s00384-003-0539-3).
• Nakayama, M. et al. Hypomethylation status of CpG sites at the promoter region and overexpression of the human MDR1 gene in acute myeloid leukemias. Blood 92, 4296–4307 (1998).
  CAS PubMed Google Scholar
• Takaguchi, M., Achanzar, W. E., Qu, W., Li, G. & Waalkes, M. P. Effects of cadmium on DNA-(Cytosine-5) methyltransferase activity and DNA methylation status during cadmium-induced cellular transformation. Exp. Cell Res. 286, 355–365 (2003).
  Google Scholar
• Okoji, R. S., Yu, R. C., Maronpot, R. R. & Froines, J. R. Sodium arsenite administration via drinking water increases genome-wide and Ha-ras DNA hypomethylation in methyl-deficient C57BL/6J mice. Carcinogenesis 23, 777–785 (2002).
  CAS PubMed Google Scholar
• Li, H. & Minarovits, J. Host cell-dependent expression of latent Epstein–Barr virus genomes: regulation by DNA methylation. Adv. Cancer Res. 89, 133–156 (2003).
  CAS PubMed Google Scholar
• Heijmans, B. T. et al. A common variant of the methylenetetrahydrofolate reductase gene (1p36) is associated with an increased risk of cancer. Cancer Res. 63, 1249–1253 (2003).
  CAS PubMed Google Scholar
• Chen, J. et al. A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res. 56, 4862–4864 (1996).
  CAS PubMed Google Scholar
• Pufulete, M. et al. Folate status, genomic DNA hypomethylation, and risk of colorectal adenoma and cancer: a case control study. Gastroenterology 124, 1240–1248 (2003).
  CAS PubMed Google Scholar
• Poirier, L. A. Folate deficiency in rats bearing the Walker tumor 256 and the Novikoff hepatoma. Cancer Res. 33, 2109–2113 (1973).
  CAS PubMed Google Scholar
• Gibbons, R. J. et al. Mutations in ATRX, encoding a SWI/SNF-like protein, cause diverse changes in the pattern of DNA methylation. Nature Genet. 24, 368–371 (2000).
  CAS PubMed Google Scholar
• Versteege, I. et al. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 394, 203–206 (1998).
  CAS PubMed Google Scholar
• Fan, T. et al. Lsh-deficient murine embryonal fibroblasts show reduced proliferation with signs of abnormal mitosis. Cancer Res. 63, 4677–4683 (2003).
  CAS PubMed Google Scholar
• Saito, Y. et al. Overexpression of a splice variant of DNA methyltransferase 3b, DNMT3b4, associated with DNA hypomethylation on pericentromeric satellite regions during human hepatocarcinogenesis. Proc. Natl Acad. Sci. USA 99, 10060–10065 (2002).
  CAS PubMed PubMed Central Google Scholar
• Baylin, S. B. et al. DNA methylation patterns of the calcitonin gene in human lung cancers and lymphomas. Cancer Res. 46, 2917–2922 (1986).
  CAS PubMed Google Scholar
• Greger, V., Passarge, E., Hopping, W., Messmer, E. & Horsthemke, B. Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma. Hum. Genet. 83, 155–158 (1989).
  CAS PubMed Google Scholar
• Sakai, T. et al. Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene. Am. J. Hum. Genet. 48, 880–888 (1991).
  CAS PubMed PubMed Central Google Scholar
• Ohtani-Fujita, N. et al. CpG methylation inactivates the promoter activity of the human retinoblastoma tumor-suppressor gene. Oncogene 8, 1063–1067 (1993).
  CAS PubMed Google Scholar
• Greger, V. et al. Frequency and parental origin of hypermethylated RB1 alleles in retinoblastoma. Hum. Genet. 94, 491–496 (1994).
  CAS PubMed Google Scholar
• Gonzalez-Zulueta, M. et al. Methylation of the 5′ Cpg island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res. 55, 4531–4535 (1995).
  CAS PubMed Google Scholar
• Graff, J. R. et al. E-Cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res. 55, 5195–5199 (1995).
  CAS PubMed Google Scholar
• Herman, J. G. et al. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc. Natl Acad. Sci. USA 91, 9700–9704 (1994).
  CAS PubMed PubMed Central Google Scholar
• Merlo, A. et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nature Med. 1, 686–692 (1995).
  Article CAS PubMed Google Scholar
• Cunningham, J. M. et al. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res. 58, 3455–3460 (1998).
  CAS PubMed Google Scholar
• Veigl, M. L. et al. Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers. Proc. Natl Acad. Sci. USA 95, 8698–8702 (1998).
  CAS PubMed PubMed Central Google Scholar
• Toyota, M. et al. CpG island methylator phenotype in colorectal cancer. Proc. Natl Acad. Sci. USA 96, 8681–8686 (1999).
  CAS PubMed PubMed Central Google Scholar
• West, R. W. & Barrett, J. C. Inactivation of a tumor suppressor function in immortal Syrian hamster cells by N-methyl-N′-nitro-N-nitrosoguanidine and by 5-aza-2′-deoxycytidine. Carcinogenesis 14, 285–289 (1993).
  CAS PubMed Google Scholar
• Rhee, I. et al. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 416, 552–556 (2002).
  CAS PubMed Google Scholar
• Robert, M. F. et al. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells. Nature Genet. 33, 61–65 (2003).
  CAS PubMed Google Scholar
• Bestor, T. H. Unanswered questions about the role of promoter methylation in carcinogenesis. Ann. NY Acad. Sci. 983, 22–27 (2003).
  CAS PubMed Google Scholar
• Hajra, K. M., Ji, X. & Fearon, E. R. Extinction of E-cadherin expression in breast cancer via a dominant repression pathway acting on proximal promoter elements. Oncogene 18, 7274–7279 (1999).
  CAS PubMed Google Scholar
• Bachman, K. E. et al. Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene. Cancer Cell 3, 89–95 (2003).
  CAS PubMed Google Scholar
• Clark, S. J. & Melki, J. DNA methylation and gene silencing in cancer: which is the guilty party? Oncogene 21, 5380–5387 (2002).
  CAS PubMed Google Scholar
• Ehrlich, M. et al. Hypomethylation and hypermethylation of DNA in Wilms tumors. Oncogene 21, 6694–6702 (2002).
  CAS PubMed Google Scholar
• Van Zee, K. J., Calvano, J. E. & Bisogna, M. Hypomethylation and increased gene expression of p16 INK4a in primary and metastatic breast carcinoma as compared to normal breast tissue. Oncogene 16, 2723–2727 (1998).
  CAS PubMed Google Scholar
• Surani, M. A., Barton, S. C. & Norris, M. L. Development of reconstituted mouse eggs suggests imprinting of the genome during gametogenesis. Nature 308, 548–550 (1984).
  CAS PubMed Google Scholar
• McGrath, J. & Solter, D. Completion of mouse embryogenesis requires both the maternal and paternal genomes. Cell 37, 179–183 (1984).
  CAS PubMed Google Scholar
• Kajii, T. & Ohama, K. Androgenetic origin of hydatidiform mole. Nature 268, 633 (1977).
  CAS PubMed Google Scholar
• Linder, D., McCaw, B., Kaiser, X. & Hecht, F. Parthenogenetic origin of benign ovarian teratomas. N. Engl. J. Med. 292, 63–66 (1975).
  CAS PubMed Google Scholar
• Pal, N. et al. Preferential loss of maternal alleles in sporadic Wilms' tumor. Oncogene 5, 1665–1668 (1990).
  CAS PubMed Google Scholar
• Schroeder, W. T. et al. Nonrandom loss of maternal chromosome 11 alleles in Wilms tumors. Am. J. Hum. Genet. 40, 413–420 (1987).
  CAS PubMed PubMed Central Google Scholar
• Scrable, H. et al. A model for embryonal rhabdomyosarcoma tumorigenesis that involves genome imprinting. Proc. Natl Acad. Sci. USA 86, 7480–7484 (1989).
  CAS PubMed PubMed Central Google Scholar
• Williams, J. C., Brown, K. W., Mott, M. G. & Maitland, N. J. Maternal allele loss in Wilms' tumor. Lancet 1, 283–284 (1989).
  CAS PubMed Google Scholar
• Brown, K. W., Williams, J. C., Maitland, N. J. & Mott, M. G. Genomic imprinting and the Beckwith–Wiedemann syndrome. Am. J. Hum. Genet. 46, 1000–1001 (1990).
  CAS PubMed PubMed Central Google Scholar
• Koufos, A. et al. Familial Wiedemann–Beckwith syndrome and a second Wilms tumor locus both map to 11p15.5. Am. J. Hum. Genet. 44, 711–719 (1989).
  CAS PubMed PubMed Central Google Scholar
• Ping, A. J. et al. Genetic linkage of Beckwith–Wiedemann syndrome to 11p15. Am. J. Hum. Genet. 44, 720–723 (1989).
  CAS PubMed PubMed Central Google Scholar
• Mannens, M. et al. Parental imprinting of human chromosome region 11p15.3-pter involved in the Beckwith–Wiedemann syndrome and various human neoplasia. Eur. J. Hum. Genet. 2, 3–23 (1994).
  CAS PubMed Google Scholar
• Zhang, Y. & Tycko, B. Monoallelic expression of the human H19 gene. Nature Genet. 1, 40–44 (1992).
  CAS PubMed Google Scholar
• Giannoukakis, N., Deal, C., Paquette, J., Goodyer, C. G. & Polychronakos, C. Parental genomic imprinting of the human IGF2 gene. Nature Genet. 4, 98–101 (1993).
  CAS PubMed Google Scholar
• Ohlsson, R. et al. IGF2 is parentally imprinted during human embryogenesis and in the Beckwith–Wiedemann syndrome. Nature Genet. 4, 94–97 (1993).
  CAS PubMed Google Scholar
• Rainier, S. et al. Relaxation of imprinted genes in human cancer. Nature 362, 747–749 (1993).
  CAS PubMed Google Scholar
• Ogawa, O. et al. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature 362, 749–751 (1993).
  CAS PubMed Google Scholar
• Barlow, D. P., Stoger, R., Herrmann, B. G., Saito, K. & Schweifer, N. The mouse insulin-like growth factor type-2 receptor is imprinted and closely linked to the Tme locus. Nature 349, 84–87 (1991).
  CAS PubMed Google Scholar
• Bartolomei, M., Zemel, S. & Tilghman, S. M. Parental imprinting of the mouse H19 gene. Nature 351, 153–155 (1991).
  CAS PubMed Google Scholar
• DeChiara, T. M., Robertson, E. J. & Efstratiadis, A. Parental imprinting of the mouse insulin-like growth factor-2 gene. Cell 64, 849–859 (1991).
  CAS PubMed Google Scholar
• Glenn, C. C., Porter, K. A., Jong, M. T., Nicholls, R. D. & Driscoll, D. J. Functional imprinting and epigenetic modification of the human SNRPN gene. Hum Mol. Genet. 2, 2001–2005 (1993).
  CAS PubMed Google Scholar
• Leff, S. E. et al. Maternal imprinting of the mouse Snrpn gene and conserved linkage homology with the human Prader–Willi syndrome region. Nature Genet. 2, 259–264 (1992).
  CAS PubMed Google Scholar
• Li, E., Beard, C. & Jaenisch, R. Role for DNA methylation in genomic imprinting. Nature 366, 362–365 (1993).
  CAS PubMed Google Scholar
• Onyango, P. et al. Sequence and comparative analysis of the mouse 1 megabase region orthologous to the human 11p15 imprinted domain. Genome Res. 10, 1697–1710 (2000).
  CAS PubMed Google Scholar
• Paulsen, M. et al. Syntenic organization of the mouse distal chromosome 7 imprinting cluster and the Beckwith–Wiedemann syndrome region in chromosome 11p15.5. Hum. Mol. Genet. 7, 1149–1159 (1998).
  CAS PubMed Google Scholar
• Qian, N. et al. The IPL gene on chromosome 11p15.5 is imprinted in humans and mice and is similar to TDAG51, implicated in Fas expression and apoptosis. Hum. Mol. Genet. 6, 2021–2029 (1997).
  CAS PubMed Google Scholar
• Dao, D. et al. IMPT1, an imprinted gene similar to polyspecific transporter and multi-drug resistance genes. Hum. Mol. Genet. 7, 597–608 (1998).
  CAS PubMed Google Scholar
• Moulton, T. et al. Epigenetic lesions at the H19 locus in Wilms' tumour patients. Nature Genet. 7, 440–447 (1994).
  CAS PubMed Google Scholar
• Steenman, M. J. et al. Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour. Nature Genet 7, 433–439 (1994).
  CAS PubMed Google Scholar
• Okamoto, K., Morison, I. M., Taniguchi, T. & Reeve, A. E. Epigenetic changes at the insulin-like growth factor II/H19 locus in developing kidney is an early event in Wilms tumorigenesis. Proc. Natl Acad. Sci. USA 94, 5367–5371 (1997).
  CAS PubMed PubMed Central Google Scholar
• Hao, Y., Crenshaw, T., Moulton, T., Newcomb, E. & Tycko, B. Tumor-suppressor activity of H19 RNA. Nature 365, 764–767 (1993).
  CAS PubMed Google Scholar
• Christofori, G., Naik, P. & Hanahan, D. Deregulation of both imprinted and expressed alleles of the insulin-like growth factor 2 gene during β-cell tumorigenesis. Nature Genet. 10, 196–201 (1995).
  CAS PubMed Google Scholar
• Christofori, G., Naik, P. & Hanahan, D. A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis. Nature 369, 414–418 (1994).
  CAS PubMed Google Scholar
• Ravenel, J. D. et al. Loss of imprinting of insulin-like growth factor-II (IGF2) gene in distinguishing specific biologic subtypes of Wilms tumor. J. Natl Cancer Inst. 93, 1698–1703 (2001).
  CAS PubMed Google Scholar
• Sanson, M., Leuraud, P., Marie, Y., Delattre, J. Y. & Hoang-Xuan, K. Preferential loss of paternal 19q, but not 1p, alleles in oligodendrogliomas. Ann. Neurol. 52, 105–107 (2002).
  CAS PubMed Google Scholar
• Maegawa, S. et al. Epigentic silencing of PEG3 gene expression in human glioma cell lines. Mol. Carcinogen. 31, 1–9 (2001).
  CAS Google Scholar
• Jenkins, R. B., Curran, W., Scott, C. B. & Cairncross, G. Pilot evaluation of 1p and 19q deletions in anaplastic oligodendrogliomas collected by a national cooperative cancer treatment group. Am. J. Clin. Oncol. 24, 506–508 (2001).
  CAS PubMed Google Scholar
• Li, L. et al. Regulation of maternal behavior and offspring growth by paternally expressed Peg3. Science 284, 330–333 (1999).
  CAS PubMed Google Scholar
• Kohda, T. et al. Tumour suppressor activity of human imprinted gene PEG3 in a glioma cell line. Genes Cells 6, 237–247 (2001).
  CAS PubMed Google Scholar
• Maegawa, S. et al. Epigenetic silencing of PEG3 gene expression in human glioma cell lines. Mol. Carcinogen. 31, 1–9 (2001).
  CAS Google Scholar
• Caron, H. et al. Chromosome bands 1p35-36 contain two distinct neuroblastoma tumor suppressor loci, one of which is imprinted. Genes Chromosomes Cancer 30, 168–174 (2001).
  CAS PubMed Google Scholar
• Morison, I. M., Ellis, L. M., Teague, L. R. & Reeve, A. E. Preferential loss of maternal 9p alleles in childhood acute lymphoblastic leukemia. Blood 99, 375–377 (2002).
  CAS PubMed Google Scholar
• Yuan, J. et al. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers. Cancer Res. 63, 4174–4180 (2003).
  CAS PubMed Google Scholar
• Lee, M. P. et al. Loss of imprinting of a paternally expressed transcript, with antisense orientation to KVLQT1, occurs frequently in Beckwith–Wiedemann syndrome and is independent of insulin-like growth factor II imprinting. Proc. Natl Acad. Sci. USA 96, 5203–5208 (1999).
  CAS PubMed PubMed Central Google Scholar
• Smilinich, N. J. et al. A maternally methylated CpG island in KvLQT1 is associated with an antisense paternal transcript and loss of imprinting in Beckwith–Wiedemann syndrome. Proc. Natl Acad. Sci. USA 96, 8064–8069 (1999).
  CAS PubMed PubMed Central Google Scholar
• Buschhausen, G., Wittig, B., Graessmann, M. & Graessmann, A. Chromatin structure is required to block transcription of the methylated herpes simplex virus thymidine kinase gene. Proc. Natl Acad. Sci. USA 84, 1177–1181 (1987).
  CAS PubMed PubMed Central Google Scholar
• Keshet, I., Lieman-Hurwitz, J. & Cedar, H. DNA methylation affects the formation of active chromatin. Cell 44, 535–543 (1986).
  CAS PubMed Google Scholar
• Lewis, J. D. et al. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell 69, 905–914 (1992).
  CAS PubMed Google Scholar
• Meehan, R. R., Lewis, J. D. & Bird, A. P. Characterization of MeCP2, a vertebrate DNA binding protein with affinity for methylated DNA. Nucleic Acids Res. 20, 5085–5092 (1992).
  CAS PubMed PubMed Central Google Scholar
• Jones, P. L. et al. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nature Genet. 19, 187–191 (1998).
  CAS PubMed Google Scholar
• Nan, X. et al. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393, 386–389 (1998).
  CAS PubMed Google Scholar
• Rountree, M. R., Bachman, K. E. & Baylin, S. B. DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci. Nature Genet. 25, 269–277 (2000).
  CAS PubMed Google Scholar
• Wade, P. A. et al. Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation. Nature Genet. 23, 62–66 (1999).
  CAS PubMed Google Scholar
• Roder, K. et al. Transcriptional repression by Drosophila methyl-CpG-binding proteins. Mol. Cell Biol. 20, 7401–7409 (2000).
  CAS PubMed PubMed Central Google Scholar
• Rea, S. et al. Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature 406, 593–599 (2000).
  CAS PubMed Google Scholar
• Strahl, B. D., Ohba, R., Cook, R. G. & Allis, C. D. Methylation of histone H3 at lysine 4 is highly conserved and correlates with transcriptionally active nuclei in Tetrahymena. Proc. Natl Acad. Sci. USA 96, 14967–14972 (1999).
  CAS PubMed PubMed Central Google Scholar
• Nguyen, C. T. et al. Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2′-deoxycytidine. Cancer Res. 62, 6456–6461 (2002).
  CAS PubMed Google Scholar
• Yoder, J. A., Walsh, C. P. & Bestor, T. H. Cytosine methylation and the ecology of intragenomic parasites. Trends Genet. 13, 335–340 (1997).
  CAS PubMed Google Scholar
• Ahmad, K. & Henikoff, S. Histone H3 variants specify modes of chromatin assembly. Proc. Natl Acad. Sci. USA 99, S16477–S16484 (2002).
  Google Scholar
• Bannister, A. J., Schneider, R. & Kouzarides, T. Histone methylation: dynamic or static? Cell 109, 801–806 (2002).
  CAS PubMed Google Scholar
• Lobanenkov, V. V., Nicolas, R. H., Plumb, M. A., Wright, C. A. & Goodwin, G. H. Sequence-specific DNA-binding proteins which interact with (G + C)-rich sequences flanking the chicken c-myc gene. Eur. J. Biochem. 159, 181–188 (1986).
  CAS PubMed Google Scholar
• Holmgren, C. et al. CpG methylation regulates the Igf2/H19 insulator. Curr. Biol. 11, 1128–1130 (2001).
  CAS PubMed Google Scholar
• Hark, A. T. et al. CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus. Nature 405, 486–489 (2000).
  CAS PubMed Google Scholar
• Bell, A. C., West, A. G. & Felsenfeld, G. The protein CTCF is required for the enhancer blocking activity of vertebrate insulators. Cell 98, 387–396 (1999).
  CAS PubMed Google Scholar
• Cui, H. et al. Loss of imprinting of insulin-like growth factor-II in Wilms' tumor commonly involves altered methylation but not mutations of CTCF or its binding site. Cancer Res. 61, 4947–4950 (2001).
  CAS PubMed Google Scholar
• Cui, H. et al. Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2. Cancer Res. 62, 6442–6446 (2002).
  CAS PubMed Google Scholar
• Nakagawa, H. et al. Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCF-binding sites in colorectal cancer. Proc. Natl Acad. Sci. USA 98, 591–596 (2001).
  CAS PubMed Google Scholar
• Loukinov, D. I. et al. BORIS, a novel male germ-line-specific protein associated with epigenetic reprogramming events, shares the same 11-zinc-finger domain with CTCF, the insulator protein involved in reading imprinting marks in the soma. Proc. Natl Acad. Sci. USA 99, 6806–6811 (2002).
  CAS PubMed PubMed Central Google Scholar
• Varambally, S. et al. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419, 624–629 (2002).
  CAS PubMed Google Scholar
• DeBaun, M. R. & Tucker, M. A. Risk of cancer during the first four years of life in children from The Beckwith–Wiedemann Syndrome Registry. J. Pediatr. 132, 398–400 (1998).
  CAS PubMed Google Scholar
• Weksberg, R., Shen, D. R., Fei, Y. L., Song, Q. L., & Squire, J. Disruption of insulin-like growth factor 2 imprinting in Beckwith–Wiedemann syndrome. Nature Genet. 5, 143–150 (1993).
  CAS PubMed Google Scholar
• Hatada, I. et al. An imprinted gene p57KIP2 is mutated in Beckwith–Wiedemann syndrome. Nature Genet. 14, 171–1733 (1996).
  CAS PubMed Google Scholar
• Tycko, B. Genomic imprinting and cancer. Results Probl. Cell. Differ. 25, 133–169 (1999).
  CAS PubMed Google Scholar
• Engel, J. R. et al. Epigenotype-phenotype correlations in Beckwith–Wiedemann syndrome. J. Med. Genet. 37, 921–926 (2000).
  CAS PubMed PubMed Central Google Scholar
• Bliek, J. et al. Increased tumour risk for BWS patients correlates with aberrant H19 and not KCNQ1OT1 methylation: occurrence of KCNQ1OT1 hypomethylation in familial cases of BWS. Hum. Mol. Genet. 10, 467–476 (2001).
  CAS PubMed Google Scholar
• Weksberg, R. et al. Tumor development in the Beckwith–Wiedemann syndrome is associated with a variety of constitutional molecular 11p15 alterations including imprinting defects of KCNQ1OT1. Hum. Mol. Genet. 10, 2989–3000 (2001).
  CAS PubMed Google Scholar
• DeBaun, M. R. et al. Epigenetic alterations of H19 and LIT1 distinguish patients with Beckwith–Wiedemann syndrome with cancer and birth defects. Am. J. Hum. Genet. 70, 604–611 (2002).
  CAS PubMed PubMed Central Google Scholar
• DeBaun, M. R., Niemitz, E. L. & Feinberg, A. P. Association of in vitro fertilization with Beckwith–Wiedemann syndrome and epigenetic alterations of LIT1 and H19. Am. J. Hum. Genet. 72, 156–160 (2002).
  PubMed PubMed Central Google Scholar
• Maher, E. R. et al. Beckwith–Wiedemann syndrome and assisted reproduction technology (ART). J. Med. Genet. 40, 62–64 (2003).
  CAS PubMed PubMed Central Google Scholar
• Cui, H. et al. Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science 299, 6442–6446 (2003).
  Google Scholar
• Belinsky, S. A. et al. Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. Proc. Natl Acad. Sci. USA 95, 11891–11896 (1998).
  CAS PubMed PubMed Central Google Scholar
• Sandovici, I. et al. Familial aggregation of abnormal methylation of parental alleles at the IGF2/H19 and IGF2R differentially methylated regions. Hum. Mol. Genet. 12, 1569–1578 (2003).
  CAS PubMed Google Scholar
• Laird, P. W. et al. Suppression of intestinal neoplasia by DNA hypomethylation. Cell 81, 197–205 (1995).
  CAS PubMed Google Scholar
• Gaudet, F. et al. Induction of tumors in mice by genomic hypomethylation. Science 300, 489–492 (2003).
  CAS PubMed Google Scholar
• Chen, W. Y. et al. Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors. Nature Genet. 33, 197–202 (2003).
  CAS PubMed Google Scholar
• Ziemin-van der Poel, S. et al. Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias. Proc. Natl Acad. Sci. USA 88, 10735–10739 (1991).
  CAS PubMed PubMed Central Google Scholar
• Tkachuk, D. C., Kohler, S. & Cleary, M. L. Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias. Cell 71, 691–700 (1992).
  CAS PubMed Google Scholar
• Gu, Y. et al. The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene. Cell 71, 701–708 (1992).
  CAS PubMed Google Scholar
• Nakamura, T. et al. ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation. Mol. Cell 10, 1119–1128 (2002).
  CAS PubMed Google Scholar
• El-Deiry, W. S. et al. High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancer. Proc. Natl Acad. Sci. USA 88, 3470–3474 (1991).
  CAS PubMed PubMed Central Google Scholar
• Lee, P. J. et al. Limited upregulation of DNA methyltransferase in human colon cancer reflecting increased cell proliferation. Proc. Natl Acad. Sci. USA 93, 10366–10370 (1996).
  CAS PubMed PubMed Central Google Scholar
• De Marzo, A. M. et al. Abnormal regulation of DNA methyltransferase expression during colorectal carcinogenesis. Cancer Res. 59, 3855–3860 (1999).
  CAS PubMed Google Scholar
• Eads, C. A. et al. CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression. Cancer Res. 59, 2302–2306 (1999).
  CAS PubMed Google Scholar
• Di Croce, L. et al. Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Science 295, 1079–1082 (2002).
  CAS PubMed Google Scholar
• Esteller, M. et al. Cancer epigenetics and methylation. Science 297, 1807–1808 (2002).
  PubMed Google Scholar
• Hajra, K. M., Chen, D. Y. & Fearon, E. R. The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res. 62, 1613–1618 (2002).
  CAS PubMed Google Scholar
• Dunaief, J. L. et al. The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest. Cell 79, 119–130 (1994).
  CAS PubMed Google Scholar
• Luo, R. X., Postigo, A. A. & Dean, D. C. Rb interacts with histone deacetylase to repress transcription. Cell 92, 463–473 (1998).
  CAS PubMed Google Scholar
• Magnaghi-Jaulin, L. et al. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391, 601–605 (1998).
  CAS PubMed Google Scholar
• Dahiya, A., Wong, S., Gonzalo, S., Gavin, M. & Dean, D. C. Linking the Rb and polycomb pathways. Mol. Cell 8, 557–569 (2001).
  CAS PubMed Google Scholar
• Pradhan, S. & Kim, G. D. The retinoblastoma gene product interacts with maintenance human DNA (cytosine-5) methyltransferase and modulates its activity. EMBO J. 21, 779–788 (2002).
  CAS PubMed PubMed Central Google Scholar
• Robertson, K. D. et al. DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters. Nature Genet. 25, 338–342 (2000).
  CAS PubMed Google Scholar
• Steele-Perkins, G. et al. Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein-methyltransferase superfamily. Genes Dev. 15, 2250–2262 (2001).
  CAS PubMed PubMed Central Google Scholar
• Hsiao, W. -L., Gattoni-Celli, S. & Weinstein, I. B. Effects of 5-azacytidine on the progressive nature of cell transformation. Mol. Cell. Biol. 5, 1800–1803 (1985).
  CAS PubMed PubMed Central Google Scholar
• Taylor, S. M. & Jones, P. A. Multiple new phenotypes induced in 10T 1/2 and 3T3 cells treated with 5-azacytidine. Cell 17, 771–779 (1979).
  CAS PubMed Google Scholar
• Daskalakis, M. et al. Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-aza-2′-deoxycytidine (decitabine) treatment. Blood 100, 2957–2964 (2002).
  CAS PubMed Google Scholar
• Juttermann, R., Li, E. & Jaenisch, R. Toxicity of 5-aza-2′-deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation. Proc. Natl Acad. Sci. USA 91, 11797–11801 (1994).
  CAS PubMed PubMed Central Google Scholar
• Cheng, J. C. et al. Inhibition of DNA methylation and reactivation of silenced genes by zebularine. J. Natl Cancer Inst. 95, 399–409 (2003).
  CAS PubMed Google Scholar
• Barletta, J. M., Rainier, S. & Feinberg, A. P. Reversal of loss of imprinting in tumor cells by 5-aza-2′-deoxycytidine. Cancer Res. 57, 48–50 (1997).
  CAS PubMed Google Scholar
• Cameron, E. E., Bachman, K. E., Myohanen, S., Herman, J. G. & Baylin, S. B. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nature Genet. 21, 103–107 (1999).
  CAS PubMed Google Scholar
• Shaker, S., Bernstein, M., Momparler, L. F. & Momparler, R. L. Preclinical evaluation of antineoplastic activity of inhibitors of DNA methylation (5-aza-2′-deoxycytidine) and histone deacetylation (trichostatin A, depsipeptide) in combination against myeloid leukemic cells. Leuk. Res. 27, 437–444 (2003).
  CAS PubMed Google Scholar
• Eden, A., Gaudet, F. & Jaenisch, R. Response to comment on “Chromosomal instability and tumors promoted by dna hypomethylation” and “Induction of tumors in mice by genomic hypomethylation”. Science 302, 1153 (2003).
  CAS Google Scholar
• Yang, A. S., Estecio, M. R., Garcia–Manero, G., Kantarjian, H. M. & Issa, J. P. Comment on “Chromosomal instability and tumors promoted by DNA hypomethylation” and “Induction of tumors in nice by genomic hypomethylation”. Science 302, 1153 (2003).
  CAS PubMed Google Scholar
• Mohandas, T., Sparkes, R. S. & Shapiro, L. J. Reactivation of an inactive human X chromosome: evidence for X inactivation by DNA methylation. Science 211, 393–396 (1981).
  CAS PubMed Google Scholar
• Wolf, S. F., Jolly, D. J., Lunnen, K. D., Friedmann, T., & Migeon, B. R. Methylation of the hypoxanthine phosphoribosyltransferase locus on the human X chromosome: implications for X-chromosome inactivation. Proc. Natl Acad. Sci. USA 81, 2806–2810 (1984).
  CAS PubMed PubMed Central Google Scholar
• Antequera, F., Macleod, D. & Bird, A. P. Specific protection of methylated CpGs in mammalian nuclei. Cell 58, 509–517 (1989).
  CAS PubMed Google Scholar
• Hansen, R. S. & Gartler, S. M. 5-azacytidine-induced reactivation of the human X chromosome-linked PGK1 gene is associated with a large region of cytosine demethylation in the 5′ CpG island. Proc. Natl Acad. Sci. USA 87, 4174–4178 (1990).
  CAS PubMed PubMed Central Google Scholar
• Jeppesen, P. & Turner, B. M. The inactive X chromosome in female mammals is distinguished by a lack of histone H4 acetylation, a cytogenetic marker for gene expression. Cell 74, 281–289 (1993).
  CAS PubMed Google Scholar